Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Baxter
McKesson
Johnson and Johnson
Colorcon

Last Updated: May 26, 2022

Siponimod fumaric acid - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for siponimod fumaric acid and what is the scope of freedom to operate?

Siponimod fumaric acid is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Siponimod fumaric acid has one hundred and thirty-eight patent family members in thirty-nine countries.

One supplier is listed for this compound.

Summary for siponimod fumaric acid
International Patents:138
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
DailyMed Link:siponimod fumaric acid at DailyMed

US Patents and Regulatory Information for siponimod fumaric acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis MAYZENT siponimod fumaric acid TABLET;ORAL 209884-003 Aug 24, 2021 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Novartis MAYZENT siponimod fumaric acid TABLET;ORAL 209884-003 Aug 24, 2021 RX Yes No See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Novartis MAYZENT siponimod fumaric acid TABLET;ORAL 209884-001 Mar 26, 2019 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Novartis MAYZENT siponimod fumaric acid TABLET;ORAL 209884-003 Aug 24, 2021 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for siponimod fumaric acid

Country Patent Number Title Estimated Expiration
Brazil PI0410439 compostos e composições imunossupressoras See Plans and Pricing
Canada 2524047 COMPOSES IMMUNOSUPPRESSEURS ET COMPOSITIONS (IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS) See Plans and Pricing
Australia 2004240637 Immunosuppressant compounds and compositions See Plans and Pricing
Japan 5941110 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for siponimod fumaric acid

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2379069 LUC00160 Luxembourg See Plans and Pricing PRODUCT NAME: SIPONIMOD; AUTHORISATION NUMBER AND DATE: EU/1/19/1414 20200115
2379069 C02379069/01 Switzerland See Plans and Pricing PRODUCT NAME: SIPONIMOD; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67230 22.10.2020
2379069 PA2020513 Lithuania See Plans and Pricing PRODUCT NAME: SIPONIMODAS; REGISTRATION NO/DATE: EU/1/19/1414 20200113
2379069 C202030029 Spain See Plans and Pricing PRODUCT NAME: SIPONIMOD; NATIONAL AUTHORISATION NUMBER: EU/1/19/1414; DATE OF AUTHORISATION: 20200113; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/19/1414; DATE OF FIRST AUTHORISATION IN EEA: 20200113
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Dow
Merck
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.